The SocietyMore than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS communityBecome an ERS member
The Executive Committee both manages and represents ERS by directing and conducting the general activities of the Society on behalf of the General Assembly. The Executive Committee provides an annual report on all activities to the General Assembly.
Personal Travel Grants or expenses for conferences etc.
None
Shares in any Relevant Companies (excluding mutual funds)
None
2 - Non-Personal interests
Company
Nature of Support
Amount of funds received*
Johnson and Johnson (Janssen)
Pulmonary hypertension translation research
D
MSD
Pulmonary hypertension translation research
D
Acceleron
Pulmonary hypertension translation research
D
Shou Ti
Pulmonary hypertension translation research
D
3 - Other Interests that may be seen as potential conflicts
None
4 - Tobacco-Industry related Conflicts of Interests
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
Personal Travel Grants or expenses for conferences etc.
None
Shares in any Relevant Companies (excluding mutual funds)
None
2 - Non-Personal interests
None
3 - Other Interests that may be seen as potential conflicts
None
4 - Tobacco-Industry related Conflicts of Interests
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
Personal Travel Grants or expenses for conferences etc.
None
Shares in any Relevant Companies (excluding mutual funds)
None
2 - Non-Personal interests
Company
Nature of Support
Amount of funds received*
Boehringer Ingelheim
Educational Grants
C
Roche
Educational Grants
C
Novartis
Educational Grants
C
Astra Zeneca
Educational Grants
C
GSK
Educational Grants
C
BMS
Educational Grants
C
MSD
Educational Grants
C
3 - Other Interests that may be seen as potential conflicts
None
4 - Tobacco-Industry related Conflicts of Interests
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
Personal Travel Grants or expenses for conferences etc.
None
Shares in any Relevant Companies (excluding mutual funds)
None
2 - Non-Personal interests
None
3 - Other Interests that may be seen as potential conflicts
None
4 - Tobacco-Industry related Conflicts of Interests
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
Personal Travel Grants or expenses for conferences etc.
None
Shares in any Relevant Companies (excluding mutual funds)
None
2 - Non-Personal interests
None
3 - Other Interests that may be seen as potential conflicts
None
4 - Tobacco-Industry related Conflicts of Interests
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
Respiratory and infectious diseases portfolios, consultancy paid to the University
C
Personal Benefits
None
Personal Travel Grants or expenses for conferences etc.
None
Shares in any Relevant Companies (excluding mutual funds)
None
2 - Non-Personal interests
Company
Nature of Support
Amount of funds received*
GSK, AZ, Novartis, Genentech, Roche, Sanofi, Regeneron, Synairgen, Mologic, 4DPharma
Research grants
D
3 - Other Interests that may be seen as potential conflicts
None
4 - Tobacco-Industry related Conflicts of Interests
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
Personal Travel Grants or expenses for conferences etc.
None
Shares in any Relevant Companies (excluding mutual funds)
None
2 - Non-Personal interests
Company
Nature of Support
Amount of funds received*
MSD
Institutional Grant
B
Astra zeneca
Institutionai Grant
A
3 - Other Interests that may be seen as potential conflicts
Company or organisation
Nature/Purpose of Support
GARD/WHO
Chair
GINA
Board of Directors
4 - Tobacco-Industry related Conflicts of Interests
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
Personal Travel Grants or expenses for conferences etc.
None
Shares in any Relevant Companies (excluding mutual funds)
None
2 - Non-Personal interests
None
3 - Other Interests that may be seen as potential conflicts
None
4 - Tobacco-Industry related Conflicts of Interests
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
Personal Travel Grants or expenses for conferences etc.
None
Shares in any Relevant Companies (excluding mutual funds)
None
2 - Non-Personal interests
Company
Nature of Support
Amount of funds received*
Fondation Air Liquide
Research grant on post-COVID lung function follow-up
D
3 - Other Interests that may be seen as potential conflicts
None
4 - Tobacco-Industry related Conflicts of Interests
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
Personal Travel Grants or expenses for conferences etc.
None
Shares in any Relevant Companies (excluding mutual funds)
None
2 - Non-Personal interests
None
3 - Other Interests that may be seen as potential conflicts
None
4 - Tobacco-Industry related Conflicts of Interests
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
*Funds Code Legend
A
B
C
D
less than € 1'000
€ 1001 - € 5'000
€ 5'001 - € 20'000
more than € 20'000
Peter Wijkstra
Treasurer Elect
Judith Garcia Aymerich
Secretary General Elect
Nicolas Roche
Science Council Chair Elect
All ERS Assembly Heads are also members of the Executive Committee.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.